 Ricka Messer
Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anticonvulsants | 2 | 2020 | 209 | 0.900 |
Why?
| | Adrenocorticotropic Hormone | 2 | 2020 | 133 | 0.790 |
Why?
| | Spasms, Infantile | 2 | 2020 | 122 | 0.720 |
Why?
| | Glucocorticoids | 2 | 2020 | 580 | 0.600 |
Why?
| | Neurology | 3 | 2023 | 103 | 0.530 |
Why?
| | Receptors, GABA-B | 1 | 2012 | 9 | 0.390 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1501 | 0.380 |
Why?
| | Benzoxazines | 1 | 2012 | 30 | 0.380 |
Why?
| | Naphthalenes | 1 | 2012 | 57 | 0.370 |
Why?
| | CA1 Region, Hippocampal | 1 | 2012 | 51 | 0.370 |
Why?
| | Morpholines | 1 | 2012 | 122 | 0.360 |
Why?
| | Cannabinoids | 1 | 2012 | 154 | 0.330 |
Why?
| | Epilepsy | 1 | 2012 | 322 | 0.280 |
Why?
| | Migraine Disorders | 1 | 2025 | 101 | 0.210 |
Why?
| | Craniocerebral Trauma | 1 | 2025 | 151 | 0.210 |
Why?
| | Internship and Residency | 2 | 2023 | 1050 | 0.210 |
Why?
| | Neurodevelopmental Disorders | 1 | 2025 | 155 | 0.200 |
Why?
| | Neurotransmitter Uptake Inhibitors | 1 | 2021 | 3 | 0.180 |
Why?
| | Dyskinesia, Drug-Induced | 1 | 2021 | 12 | 0.180 |
Why?
| | Brain Diseases | 1 | 2021 | 136 | 0.160 |
Why?
| | Prednisolone | 1 | 2019 | 82 | 0.160 |
Why?
| | Child Abuse | 1 | 2025 | 512 | 0.160 |
Why?
| | Enterovirus | 1 | 2019 | 78 | 0.160 |
Why?
| | Antidepressive Agents | 1 | 2021 | 229 | 0.150 |
Why?
| | Brain Injuries, Traumatic | 1 | 2023 | 341 | 0.150 |
Why?
| | Healthcare Disparities | 1 | 2025 | 578 | 0.150 |
Why?
| | Bipolar Disorder | 1 | 2021 | 235 | 0.150 |
Why?
| | Critical Illness | 1 | 2023 | 758 | 0.140 |
Why?
| | Enterovirus Infections | 1 | 2019 | 171 | 0.130 |
Why?
| | Nervous System Diseases | 1 | 2019 | 251 | 0.130 |
Why?
| | Pregnancy Complications | 1 | 2021 | 493 | 0.130 |
Why?
| | Infant | 4 | 2025 | 8995 | 0.120 |
Why?
| | Emergency Service, Hospital | 1 | 2025 | 1914 | 0.110 |
Why?
| | Glasgow Coma Scale | 2 | 2025 | 165 | 0.110 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2021 | 811 | 0.100 |
Why?
| | Cannabinoid Receptor Modulators | 1 | 2012 | 8 | 0.100 |
Why?
| | Magnetic Resonance Imaging | 1 | 2023 | 3394 | 0.090 |
Why?
| | Organ Culture Techniques | 1 | 2012 | 155 | 0.090 |
Why?
| | Child, Preschool | 5 | 2025 | 10490 | 0.090 |
Why?
| | Drug Resistance | 1 | 2012 | 165 | 0.090 |
Why?
| | Mice, Inbred Strains | 1 | 2012 | 406 | 0.090 |
Why?
| | Hypertension | 1 | 2019 | 1243 | 0.090 |
Why?
| | Humans | 11 | 2025 | 129625 | 0.070 |
Why?
| | Child | 5 | 2025 | 20884 | 0.070 |
Why?
| | Diffuse Axonal Injury | 1 | 2023 | 8 | 0.060 |
Why?
| | Corpus Callosum | 1 | 2023 | 66 | 0.050 |
Why?
| | White Matter | 1 | 2023 | 135 | 0.050 |
Why?
| | Male | 6 | 2025 | 63670 | 0.050 |
Why?
| | North America | 1 | 2022 | 292 | 0.050 |
Why?
| | Canada | 1 | 2022 | 350 | 0.050 |
Why?
| | Quetiapine Fumarate | 1 | 2021 | 23 | 0.050 |
Why?
| | Venlafaxine Hydrochloride | 1 | 2021 | 14 | 0.040 |
Why?
| | Female | 6 | 2025 | 68734 | 0.040 |
Why?
| | Bupropion | 1 | 2021 | 40 | 0.040 |
Why?
| | Surveys and Questionnaires | 2 | 2023 | 5415 | 0.040 |
Why?
| | Colorado | 2 | 2019 | 4404 | 0.040 |
Why?
| | Causality | 1 | 2019 | 117 | 0.040 |
Why?
| | Hormones | 1 | 2019 | 141 | 0.040 |
Why?
| | Inpatients | 1 | 2022 | 475 | 0.040 |
Why?
| | Drug Therapy, Combination | 1 | 2021 | 1042 | 0.040 |
Why?
| | Emotions | 1 | 2023 | 545 | 0.040 |
Why?
| | Communication | 1 | 2023 | 838 | 0.030 |
Why?
| | Disease Outbreaks | 1 | 2019 | 349 | 0.030 |
Why?
| | Family | 1 | 2020 | 646 | 0.030 |
Why?
| | Registries | 1 | 2023 | 1899 | 0.030 |
Why?
| | Prognosis | 1 | 2023 | 3774 | 0.030 |
Why?
| | Adolescent | 2 | 2025 | 20412 | 0.030 |
Why?
| | Mice | 1 | 2012 | 16961 | 0.030 |
Why?
| | Comorbidity | 1 | 2019 | 1547 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1491 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2025 | 5075 | 0.030 |
Why?
| | Incidence | 1 | 2019 | 2641 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2019 | 14522 | 0.020 |
Why?
| | Animals | 1 | 2012 | 35391 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2021 | 5756 | 0.020 |
Why?
| | Young Adult | 1 | 2025 | 12455 | 0.020 |
Why?
| | Pregnancy | 1 | 2021 | 6417 | 0.020 |
Why?
| | United States | 1 | 2025 | 13871 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2019 | 10219 | 0.010 |
Why?
|
|
Messer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|